About Us

skip navigation
Home Resources Program Reviews & Reports Training Facility Inspection Videos Checklists Biosafety in Microbiological and Biomedical Laboratories (BMBL) Containment Facility Design and Construction (Secondary Barriers) Containment for Work with Eastern Equine Encephalitis virus Guidance for the Inactivation of Select Agents and Toxins Guidance on the Use of Infectious Waste Treatment and Radiation Facilities Outside of Registered Space Guidelines for Avian Influenza Viruses Incident Response Plan Long Term Storage NIH Guidelines Prudent Practices in the Laboratory: Handling and Management of Chemical Hazards SA Grams Security Related Information Synthetic Genomics About Us Forms APHIS/CDC Form 1 - Application for Registration for Possession, Use, and Transfer of Select Agents and Toxins APHIS/CDC Form 2 - Request to Transfer Select Agents and Toxins APHIS/CDC Form 3 - Report of Theft, Loss or Release of Select Agents or Toxins APHIS/CDC Form 4 - Report of the Identification of a Select Agent or Toxin APHIS/CDC Form 5 - Request for Exemption of Select Agents and Toxins for Public Health or Agricultural Emergency or Investigational/Experimental Product Helpful Information Regulations Legislation Privacy Statement FOIA Act Accessibility Statement Related Links Operations Security Risk Assessments Select Agents & Toxins Select Agents and Toxins List Select Agents and Toxins - Exclusions Select Agents and Toxins - Restricted Experiments Permissible Toxin Amounts FAQ's General FAQ's Report of the Identification of a Select Agent or Toxin FAQ's Security FAQ's Security Risk Assessments FAQ's Transfers FAQ's Last Updated: Friday, June 25, 2010
About Us In the wake of the Oklahoma City bombing of the Alfred E. Murrah Building in April 1995, Congress passed the Antiterrorism and Effective Death Penalty Act of 1996 in October 1996. The provisions of this act were implemented by 42 CFR 72.6. HHS delegated authority for operating the Laboratory Registration and Select Agents Tracking Program to CDC. After the terrorist events of September and October 2001, Congress passed the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act Of 2001 (USA PATRIOT Act (PDF format). This was followed in June 2002, by passage of Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (PDF format). The provisions of this Act were implemented by 42 CFR 73, Possession, Use and Transfer of Select Agents; Interim Final Rule. The IFR was published in the Federal Register (PDF format) on December 13, 2002. The IFR underwent a staged implementation, beginning February 7, 2003. Public comment was invited on the IFR between December 13, 2002 and February 11, 2003, for consideration in promulgating the Final Rule. The IFR was amended in November 2003 to provide for provisional entity registrations to prevent disruption or termination of ongoing research and educational projects by entities and individuals needing access to select agents and toxins. The U.S. Departments of Health and Human Services (HHS) and Agriculture (USDA) published final rules for the possession, use, and transfer of select agents and toxins (42 C.F.R. Part 73, 7 C.F.R. Part 331, and 9 C.F.R. Part 121) in the Federal Register on March 18, 2005. All provisions of these final rules superseded those contained in the interim final rules and became effective on April 18, 2005.	Change Text Size: A A A Print This Page
Home \| Resources \| About Us \| Forms \| Helpful Information \| Operations \| Select Agents & Toxins \| FAQ's